• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

HIV infection associated with increased cancer-specific mortality

byMonica ParksandDavid Wang
June 25, 2015
in Infectious Disease, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a retrospective review of a large cancer database of over 1.8 million patients, HIV infection was associated with increased risk of cancer-specific mortality compared to uninfected patients, regardless of cancer stage or treatment received.

Evidence Rating Level: 3 (Average)

Study Rundown: Infection with HIV is a known risk factor for malignancy, including both AIDS-defining cancers such as Kaposi sarcoma as well as non-AIDS-defining cancers such as Hodgkin lymphoma, anal, and lung cancer. The introduction of effective antiretroviral therapy has significantly improved the survival of patients with HIV. However, the effect of HIV infection on cancer-specific mortality has not been well-established. The purpose of this retrospective review was to evaluate the effect of HIV infection on cancer-related mortality. The authors performed a retrospective review of a linkage database of two large HIV/AIDS and cancer databases from the United States from 1996 to 2010 and compared the cancer-specific mortality rates of over 6,000 HIV-infected patients and 1.8 million uninfected patients.

At the conclusion of the study, the authors found that HIV-infected patients had a greater cancer-specific mortality for several different types of common cancers (i.e. colorectal, lung, melanoma, breast) compared to uninfected patients. HIV-infected patients were more likely to present at a later cancer stage and to not undergo any cancer treatment compared to non-infected patients. However, the increased risk of cancer-specific mortality in the HIV-infected cohort remained even after adjusting for these variables. The results of this study support the hypothesis that HIV-infection may increase the risk of cancer-specific mortality independent of cancer stage or type of care received. However, the study is limited by the retrospective nature of the study as well as the use of death certificate reports as the cause of death, which may reduce the accuracy of the data. Additional, large prospective trials are required to more accurately characterize this association.

Click to read the study in JCO

Relevant Reading: Trends in cancer risk among people with AIDS in the United States 1980-2002

In-Depth [retrospective cohort]: This study was a retrospective analysis of data from the HIV/AIDS Cancer Match (HACM) study, which linked 14 population-based HIV and cancer registries in the United States from 6 different states. The authors included patients diagnosed with one of 14 common cancers, including cancers of the oral cavity/pharynx, colorectal, anus, liver, pancreas, larynx, lung, breast, cervix, prostate, kidney/renal pelvis, Hodgkin’s Lymphoma, diffuse large B-cell lymphoma and melanoma from 1996 to 2010. The primary outcome was cancer-specific mortality. Other outcomes included all-cause mortality and HIV-specific mortality. A total of 1,816,461 patients were included in this study, of which 6,459 was infected with HIV. At the conclusion of the study, HIV-infected patients had overall increased cancer-specific mortality for 7 of the 14 cancers compared to non-infected cohort: colorectal (HR: 1.49; 95% CI: 1.21 to 1.84), pancreas (HR: 1.71; 95% CI: 1.35 to 2.18), larynx (HR: 1.62; 95% CI: 1.06 to 2.47), lung (HR: 1.28; 95% CI: 1.17 to 1.39), melanoma (HR: 1.72; 95% CI: 1.09 to 2.70), breast (HR: 2.61; 95% CI: 2.06 to 3.31), and prostate (HR: 1.57; 95% CI: 1.02 to 2.41). Patients with HIV-infections was diagnosed with more advanced cancers (32.2% versus 17.7%, p < .01), and were less likely to receive any first-line treatment (68.6% versus 74.6%, p < .01) compared to the non-infected cohort. Adjustment for cancer treatment had little effect on this association.

RELATED REPORTS

The 2 Minute Medicine Podcast Episode 6

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

Risk scores perform moderately well in discriminating people living with HIV with higher vs lower cardiovascular disease risk

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: AIDSHIV
Previous Post

CT screen ineffective for detecting cancer in patients with blood clots [SOME Trial]

Next Post

Ebola virus rapid diagnostic test kit shows promise in point-of-care testing

RelatedReports

2MM Podcast

The 2 Minute Medicine Podcast Episode 6

January 13, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

January 11, 2023
Few high school students, young adults get HIV testing
Cardiology

Risk scores perform moderately well in discriminating people living with HIV with higher vs lower cardiovascular disease risk

January 3, 2023
Positive physician experience in the Pediatric AIDS Corps
Cardiology

Risk of cardiovascular pathology determined using advanced cardiovascular imaging limited by heterogeneity amongst patients with human immunodeficiency virus

September 17, 2022
Next Post
Ebola and Marburg vaccines safe and well tolerated in Phase 1b trial in Uganda

Ebola virus rapid diagnostic test kit shows promise in point-of-care testing

Twin-specific gestational diabetes screening guidelines needed

Skin patch delivers insulin in response to hyperglycemia [PreClinical]

Increased risk of stillbirth recurrence after a previous stillbirth

Increased risk of stillbirth recurrence after a previous stillbirth

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
  • Plant-based diets may be associated with lower risk of aggressive prostate cancer
  • #VisualAbstract: Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options